BALTIMORE, Sept. 9, 2021 /PRNewswire/ -- Medifast, Inc.
(NYSE: MED), the global company behind one of the fastest-growing
health and wellness communities, OPTAVIA®, announced
today that its Board of Directors has declared a $1.42 quarterly cash dividend to its
stockholders. The quarterly cash dividend of $1.42 per share is payable on November 8, 2021 to stockholders of record as of
the close of business on September 21,
2021.
Medifast expects to maintain a program of paying dividends on a
quarterly basis. However, the declaration of dividends in the
future is subject to the discretion of the company's Board of
Directors, who will evaluate the company's dividend program from
time to time based on factors that it deems relevant.
About Medifast®:
Medifast (NYSE: MED) is the global company behind one of the
fastest-growing health and wellness
communities, OPTAVIA®, which offers
scientifically developed products, clinically proven plans and the
support of Coaches and a Community to help Clients
achieve Lifelong Transformation, One Healthy Habit at a
Time®. Based on more than 40 years of experience,
Medifast has redefined direct selling by combining the best aspects
of the model. Its community of independent OPTAVIA
Coaches has impacted 2 million lives and teaches Clients how to
develop holistic healthy habits through the proprietary Habits of
Health® Transformational System. Medifast is traded
on the New York Stock Exchange and ranked second
on FORTUNE's 100 Fastest-Growing Companies list in 2020.
The company was also named to Forbes' 100 Most Trustworthy
Companies in America list in 2017. For more information,
visit MedifastInc.com or OPTAVIA.com and
follow @Medifast on Twitter.
Forward Looking Statements
Please Note: This release contains "forward-looking statements"
within the meaning of Section 27A of the Securities Act of 1933, as
amended, Section 21E of the Securities Exchange Act of 1934, as
amended, and the Private Securities Litigation Reform Act of 1995.
These forward-looking statements relate to future dividends.
Similarly, descriptions of Medifast's objectives, strategies,
plans, goals or targets contained herein are also considered
forward-looking statements. These statements are based on the
current expectations of the management of Medifast and are subject
to certain events, risks, uncertainties, and other factors. Some of
these factors include, among others, risks associated with
Medifast's direct-to-consumer business model, the impact of rapid
growth on Medifast's systems, disruptions in Medifast's supply
chain, Medifast's inability to continue to develop new services and
products, effectiveness of Medifast's advertising and marketing
programs, including use of social media by independent
OPTAVIA Coaches, Medifast's inability to maintain and grow
the network of independent OPTAVIA Coaches, the departure of
one or more key personnel, Medifast's inability to protect against
online security risks, to protect its brand, to protect against
product liability claims, Medifast's planned growth into domestic
and international markets, adverse publicity associated with
Medifast's products or business units, Medifast's inability to
continue declaring dividends, fluctuations of Medifast's common
stock market price, the impact of the COVID-19 pandemic on
Medifast's results, the severity, length and ultimate impact of
COVID-19 on people and economies, increases in competition,
litigation, consequences of other geopolitical events, natural
disasters, acts of war, or climate change, activist investors,
regulatory changes, market conditions and resulting impact on
consumer spending, a failure of internal control over financial
reporting and any limitations imposed by Medifast's debt
agreements. Although Medifast believes that the expectations,
statements, and assumptions reflected in these forward-looking
statements are reasonable, it cautions readers to always consider
all of the risk factors and any other cautionary statements
carefully in evaluating each forward-looking statement in this
release, as well as those set forth in its Annual Report on Form
10-K for the fiscal year ended December 31,
2020, its Quarterly Reports on Form 10-Q for the quarters
ended March 31, 2021 and June 30, 2021, and other filings filed with the
United States Securities and Exchange Commission, including its
current reports on Form 8-K. All of the forward-looking statements
contained herein speak only as of the date of this release.
MED-F
View original content to download
multimedia:https://www.prnewswire.com/news-releases/medifast-inc-announces-quarterly-dividend-301372978.html
SOURCE Medifast, Inc.